BIOMAT Database Logo BIOMAT Database Logo

Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. 1998

E Segi, and Y Sugimoto, and A Yamasaki, and Y Aze, and H Oida, and T Nishimura, and T Murata, and T Matsuoka, and F Ushikubi, and M Hirose, and T Tanaka, and N Yoshida, and S Narumiya, and A Ichikawa
Department of Physiological Chemistry, Faculty of Pharmaceutical Sciences, Kyoto University, Japan.

The physiological role of the prostaglandin E2 receptor EP4 subtype was investigated by generation of EP4-deficient-mice by gene targeting. Loss of the EP4 receptor was not lethal in utero, but most EP4 (-/-) neonates became pale and lethargic approximately 24 h after birth and died within 72 h. Less than 5% of the EP4 (-/-) mice survived and grew normally more than a year. Histological examination revealed that the ductus arteriosus in dead neonates remained open, while it was partially closed in the survivors. In situ hybridization study showed that EP4 mRNA was strongly expressed in the ductus. These results suggest that neonatal death is at least partly due to patent ductus arteriosus and that the EP4 receptor plays a role in regulation of the patency of this vessel. They also indicate that normal function of the EP4 receptor is essential in neonatal adaptation of the circulatory system.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D004373 Ductus Arteriosus A fetal blood vessel connecting the pulmonary artery with the descending aorta. Arteriosus, Ductus
D004374 Ductus Arteriosus, Patent A congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth. Patent Ductus Arteriosus Familial,Patency of the Ductus Arteriosus,Patent Ductus Arteriosus
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015232 Dinoprostone The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2

Related Publications

E Segi, and Y Sugimoto, and A Yamasaki, and Y Aze, and H Oida, and T Nishimura, and T Murata, and T Matsuoka, and F Ushikubi, and M Hirose, and T Tanaka, and N Yoshida, and S Narumiya, and A Ichikawa
Prostaglandin E2 Receptor EP4 Inhibition Contracts Rat Ductus Arteriosus.
December 2018, Circulation journal : official journal of the Japanese Circulation Society,
E Segi, and Y Sugimoto, and A Yamasaki, and Y Aze, and H Oida, and T Nishimura, and T Murata, and T Matsuoka, and F Ushikubi, and M Hirose, and T Tanaka, and N Yoshida, and S Narumiya, and A Ichikawa
Neonatal manipulation: patent ductus arteriosus.
January 1981, Cardiovascular clinics,
E Segi, and Y Sugimoto, and A Yamasaki, and Y Aze, and H Oida, and T Nishimura, and T Murata, and T Matsuoka, and F Ushikubi, and M Hirose, and T Tanaka, and N Yoshida, and S Narumiya, and A Ichikawa
Circulating prostaglandin E2 concentrations and patent ductus arteriosus in fetal and neonatal lambs.
September 1980, The Journal of pediatrics,
E Segi, and Y Sugimoto, and A Yamasaki, and Y Aze, and H Oida, and T Nishimura, and T Murata, and T Matsuoka, and F Ushikubi, and M Hirose, and T Tanaka, and N Yoshida, and S Narumiya, and A Ichikawa
[Patent ductus arteriosus in neonatal intensive care].
December 1999, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,
E Segi, and Y Sugimoto, and A Yamasaki, and Y Aze, and H Oida, and T Nishimura, and T Murata, and T Matsuoka, and F Ushikubi, and M Hirose, and T Tanaka, and N Yoshida, and S Narumiya, and A Ichikawa
Failure of postnatal ductus arteriosus closure in prostaglandin transporter-deficient mice.
February 2010, Circulation,
E Segi, and Y Sugimoto, and A Yamasaki, and Y Aze, and H Oida, and T Nishimura, and T Murata, and T Matsuoka, and F Ushikubi, and M Hirose, and T Tanaka, and N Yoshida, and S Narumiya, and A Ichikawa
Prostaglandin E2 inhibits elastogenesis in the ductus arteriosus via EP4 signaling.
January 2014, Circulation,
E Segi, and Y Sugimoto, and A Yamasaki, and Y Aze, and H Oida, and T Nishimura, and T Murata, and T Matsuoka, and F Ushikubi, and M Hirose, and T Tanaka, and N Yoshida, and S Narumiya, and A Ichikawa
Neonatal infective endarteritis complicating patent ductus arteriosus.
May 2008, Acta paediatrica (Oslo, Norway : 1992),
E Segi, and Y Sugimoto, and A Yamasaki, and Y Aze, and H Oida, and T Nishimura, and T Murata, and T Matsuoka, and F Ushikubi, and M Hirose, and T Tanaka, and N Yoshida, and S Narumiya, and A Ichikawa
Changing expression of cyclooxygenases and prostaglandin receptor EP4 during development of the human ductus arteriosus.
September 2006, Pediatric research,
E Segi, and Y Sugimoto, and A Yamasaki, and Y Aze, and H Oida, and T Nishimura, and T Murata, and T Matsuoka, and F Ushikubi, and M Hirose, and T Tanaka, and N Yoshida, and S Narumiya, and A Ichikawa
Ligation of patent ductus arteriosus: Complication and death.
December 1968, Canadian Medical Association journal,
E Segi, and Y Sugimoto, and A Yamasaki, and Y Aze, and H Oida, and T Nishimura, and T Murata, and T Matsuoka, and F Ushikubi, and M Hirose, and T Tanaka, and N Yoshida, and S Narumiya, and A Ichikawa
Patent ductus arteriosus--neonatal intensive care unit registry.
January 2008, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,
Copied contents to your clipboard!